Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Novel substance P antagonists covered by Takeda patent

Nov. 15, 2002

New 5-HT2C agonists for erectile dysfunction and other disorders under study at Yamanouchi

Nov. 15, 2002

Accelerated approval plan for KRX-101

Nov. 14, 2002

Positive results from TA-1790 erectile dysfunction study

Nov. 13, 2002

Health Canada approves irbesartan for diabetic renal disease

Nov. 13, 2002

New PDE5 inhibitors in early development at Pfizer

Nov. 13, 2002

Series of PDE5 inhibitors in early development at Tanabe Seiyaku

Nov. 11, 2002

Potential of GPI-1046 for maintaining erectile function after radical prostatectomy

Nov. 6, 2002

Prostanoid IP antagonists and their use in bladder disorders reported by Roche

Nov. 6, 2002

Tadalafil reported safe and effective in broad-spectrum erectile dysfunction

Nov. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...